View stunning SlideShares in full-screen with the new iOS app!Introducing SlideShare for AndroidExplore all your favorite topics in the SlideShare appGet the SlideShare app to Save for Later — even offline
View stunning SlideShares in full-screen with the new Android app!View stunning SlideShares in full-screen with the new iOS app!
Page 1 of 2Close Window Click here to print or select File then Print from your browser. Comparison of Vaccine Formulations: Modified Live, Killed & Toxoid Vaccines Difference Between the Inactivated and Attenuated Vaccinations By Tami Port, MS With the current double-barrel influenza threat of seasonal and H1N1 swine flu, the safety of vaccines is on everyones mind. Should you get a live or killed virus vaccine? What is the difference, and what are the pros and cons of each? The following is a comparison summary of the different categories of vaccine available. Attenuated, Live Vaccines Vaccines that are considered attenuated contain modified live viruses (MLV) or other disease-causing microbes, that have been altered in a way that weakens them to the point that they are no longer virulent, and are unable to cause disease. Viruses are typically made avirulent, by using a virulent stain to infect laboratory tissue cultures and then having the viruses reproduce for many generations until they lose their ability to cause disease. The pathogenic microbes in attenuated vaccines, although avirulent, must still be active, and able to replicate after inoculation so that they achieve adequate numbers to stimulate the bodys immune response. Pros and Cons of Attenuated Live Vaccines: * Advantage: Usually only one dose required. * Advantage: Stimulates rapid immune response after inoculation. * Advantage: The bodys immune response to the pathogen is stronger and lasts longer. * Disadvantage: Although weakened, attenuated microbes may still have enough virulence to cause disease in immune compromised patients. * Disadvantage: Rarely, attenuated microbes can revert to wild type, that are able to cause disease. Killed Inactivated Vaccines Inactivated vaccines contain microbes that have been treated by chemical or physical means to prevent them from replicating, or causing disease. Some inactivated vaccines contain the entire infectious agent (whole agent vaccines), while others include only antigenic parts of the microbe (subunit vaccines) that still stimulate the the body to launch and immune response. Pro and Cons of Inactivated Vaccines: * Advantage: Safer because there is no risk of the infectious agent replicating or reverting to a virulent form. * Advantage: Recommended for immune compromised and pregnant patients. * Disadvantage: Antigenically weak; several booster vaccines may be needed to achieve complete immunity. * Disadvantage: In whole agent vaccines, the nonantigenic portions of the microbe may result in a painful inflammatory response in some individuals. Toxoid Vaccines This type of vaccine is used to inoculate against some bacterial diseases, in which the bacterium produces a toxin. These vaccines contain a modified toxin produced by the microbe in question, which initiates an immune response in the person vaccinated. Like subunit inactivated vaccines, toxoid vaccines are generally safer than attenuated live vaccines, but induce a weaker immune response, so require multiple doses. Difference Between the H1N1 Flu Mist and Injection This flu season, there will be two types of swine flu vaccine available. The flu injectable vaccine is made with inactivated, "killed" H1N1 virus. In contrast, the mist contains an attenuated or weakened virus. The CDC indicates that the safety and efficacy data for both formulations of vaccine--nasal spray and injection--are very comparable To learn more about the official recommendations regarding the general immunization schedule and seasonal and swine flu vaccination, see the information on the CDCs influenza web pages, or read the Suite101 article on simple steps to help avoid becoming sick with influenza. Sources Bauman, R. (2004) Microbiology, Pearson Benjamin Cummings. Center for Disease Control (CDC), H1N1 Flu Web Pages, updated as of October 9, 2009. National Public Radio, Diane Rehm Show, H1N1 Vaccine Plans, aired on October 7, 2009.http://www.associatedcontent.com/shared/print.shtml?content_type=article&content_ty... 30/4/2554